Cosmo Pharmaceuticals
C43.F
#5445
Rank
S$1.90 B
Marketcap
S$111.42
Share price
-1.05%
Change (1 day)
20.79%
Change (1 year)

Revenue for Cosmo Pharmaceuticals (C43.F)

Revenue in 2025: S$0.15 Billion

According to Cosmo Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is S$0.15 Billion. In 2025 the company made a revenue of S$0.15 Billion a decrease over the revenue in the year 2024 that were of S$0.35 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cosmo Pharmaceuticals from 2004 to 2025

Annual revenue

Year Revenue Change
2025S$0.15 B-55.92%
2024S$0.35 B170.68%
2023S$0.13 B-6.34%
2022S$0.14 B48.59%
2021S$94.91 M-1.69%
2020S$96.55 M7.08%
2019S$90.16 M-6.74%
2018S$96.68 M-6.96%
2017S$0.10 B13.36%
2016S$91.66 M7.4%
2015S$85.35 M-31.54%
2014S$0.12 B24.35%
2013S$0.10 B-1.15%
2012S$0.10 B80.97%
2011S$56.04 M2.08%
2010S$54.9 M11.51%
2009S$49.24 M-19.97%
2008S$61.53 M49.4%
2007S$41.18 M59.87%
2006S$25.76 M8.89%
2005S$23.65 M22.77%
2004S$19.27 M